DK483689A - Imidazolderivater - Google Patents

Imidazolderivater Download PDF

Info

Publication number
DK483689A
DK483689A DK483689A DK483689A DK483689A DK 483689 A DK483689 A DK 483689A DK 483689 A DK483689 A DK 483689A DK 483689 A DK483689 A DK 483689A DK 483689 A DK483689 A DK 483689A
Authority
DK
Denmark
Prior art keywords
imidazole
Prior art date
Application number
DK483689A
Other languages
Danish (da)
English (en)
Other versions
DK483689D0 (da
Inventor
Nigel Stephen Watson
Chuen Chan
Barry Clive Ross
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888823192A external-priority patent/GB8823192D0/en
Priority claimed from GB888823191A external-priority patent/GB8823191D0/en
Priority claimed from GB898902847A external-priority patent/GB8902847D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK483689D0 publication Critical patent/DK483689D0/da
Publication of DK483689A publication Critical patent/DK483689A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK483689A 1988-10-03 1989-10-02 Imidazolderivater DK483689A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888823192A GB8823192D0 (en) 1988-10-03 1988-10-03 Chemical compounds
GB888823191A GB8823191D0 (en) 1988-10-03 1988-10-03 Chemical compounds
GB898902847A GB8902847D0 (en) 1989-02-09 1989-02-09 Chemical compounds

Publications (2)

Publication Number Publication Date
DK483689D0 DK483689D0 (da) 1989-10-02
DK483689A true DK483689A (da) 1990-04-04

Family

ID=27264106

Family Applications (1)

Application Number Title Priority Date Filing Date
DK483689A DK483689A (da) 1988-10-03 1989-10-02 Imidazolderivater

Country Status (19)

Country Link
US (2) US5013749A (fr)
JP (1) JPH02188571A (fr)
KR (1) KR900006297A (fr)
AU (1) AU628862B2 (fr)
BE (1) BE1003007A3 (fr)
CH (1) CH680442A5 (fr)
DE (1) DE3932887A1 (fr)
DK (1) DK483689A (fr)
ES (1) ES2019163A6 (fr)
FI (1) FI894648A (fr)
FR (1) FR2637183A1 (fr)
GB (1) GB2223224B (fr)
GR (1) GR890100634A (fr)
IT (1) IT1237470B (fr)
LU (1) LU87600A1 (fr)
NL (1) NL8902441A (fr)
NO (1) NO893909L (fr)
PT (1) PT91878B (fr)
SE (1) SE8903226L (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3913725A1 (de) * 1989-04-26 1990-10-31 Basf Ag 1-halogenvinyl-azole und diese enthaltende fungizide und wachstumsregulatoren
JPH03184961A (ja) * 1989-10-10 1991-08-12 Glaxo Group Ltd 化合物
WO2002030425A1 (fr) * 2000-10-12 2002-04-18 Nissan Chemical Industries, Ltd. Medicaments pour la prevention ou le traitement de complications du diabete
IL158300A0 (en) * 2001-04-27 2004-05-12 Bristol Myers Squibb Co Bisarylimidazol derivatives and pharmaceutical compositions containing the same
AU2005237428A1 (en) * 2004-04-16 2005-11-10 Warner-Lambert Company Llc Novel imidazoles
US20060084695A1 (en) * 2004-04-29 2006-04-20 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
WO2005115397A2 (fr) * 2004-04-29 2005-12-08 Pharmix Corporation Compositions et traitements pour moduler une kinase et/ou une hmg-coa reductase
US7183285B2 (en) * 2004-04-29 2007-02-27 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20050272770A1 (en) * 2004-04-29 2005-12-08 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7163945B2 (en) * 2004-04-29 2007-01-16 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7199126B2 (en) * 2004-04-29 2007-04-03 Pharmix Corporation Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20050282883A1 (en) * 2004-04-29 2005-12-22 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20060111436A1 (en) * 2004-11-23 2006-05-25 John Griffin Compositions and treatments for modulating kinase and/or HMG-CoA reductase
US8372877B2 (en) 2010-04-16 2013-02-12 Cumberland Pharmaceuticals Stabilized statin formulations
EP2626069A4 (fr) 2010-10-06 2014-03-19 Univ Tokyo Médicament destiné à la prévention et au traitement d'un lymph dème

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
KR900001212B1 (ko) * 1985-10-25 1990-02-28 산도즈 파마슈티칼스 코오포레이숀 메바로노락톤 및 그것의 유도체의 헤테로사이클릭 유사체 및 그것의 생산방법 및 약학적인 그것의 용도
JPS6322056A (ja) * 1986-04-30 1988-01-29 サンド・アクチエンゲゼルシヤフト オレフイン性化合物の製造法
DE3800785A1 (de) * 1988-01-09 1989-07-20 Hoechst Ag Substituierte 7-(pyridazin-5-yl)-3,5-dihydroxyheptan(en)- saeuren, ihre entsprechenden (delta)-lactone bzw. derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
NO890522L (no) * 1988-02-25 1989-08-28 Bayer Ag Substituerte imidazolinoner og imidazolinthioner.

Also Published As

Publication number Publication date
US5013749A (en) 1991-05-07
PT91878B (pt) 1995-05-31
NO893909L (no) 1990-04-04
PT91878A (pt) 1990-04-30
DK483689D0 (da) 1989-10-02
GB2223224A (en) 1990-04-04
JPH02188571A (ja) 1990-07-24
FR2637183A1 (fr) 1990-04-06
NO893909D0 (no) 1989-10-02
CH680442A5 (fr) 1992-08-31
GB8922212D0 (en) 1989-11-15
DE3932887A1 (de) 1990-04-05
SE8903226L (sv) 1990-04-04
US5120848A (en) 1992-06-09
SE8903226D0 (sv) 1989-10-02
BE1003007A3 (fr) 1991-10-22
ES2019163A6 (es) 1991-06-01
GB2223224B (en) 1992-01-08
FI894648A0 (fi) 1989-10-02
AU628862B2 (en) 1992-09-24
IT8948424A0 (it) 1989-10-02
GR890100634A (el) 1990-11-29
AU4243189A (en) 1990-04-05
IT1237470B (it) 1993-06-07
FI894648A (fi) 1990-04-04
KR900006297A (ko) 1990-05-07
NL8902441A (nl) 1990-05-01
LU87600A1 (fr) 1990-05-15

Similar Documents

Publication Publication Date Title
DK425887A (da) Imidazolderivater
ES2012750A4 (es) Conjunto recipiente-aplicador
DK611889D0 (da) 2-amino-4- eller -5-methoxycyclohexylamider
DK664989A (da) Mikrodrivapparat
DK479289D0 (da) Taeppeflise
FI92273C (fi) Signaalin levitin
DK656689A (da) Triazolderivater
DK483689A (da) Imidazolderivater
DK532589A (da) Referenceelektrode
NO176729C (no) Brönnrömmer
DK79089A (da) Saartykplaster
DK138488D0 (da) Imidazolderivater
DK392889A (da) Imidazolderivater
FI893573A (fi) Ohutkalvoelektroluminesenssilaite
DK364187D0 (da) Imidazolderivater
DK375887D0 (da) Imidazolderivater
DK165575C (da) Loeftesele
FR2631517B1 (fr) Recif-abri
DK428789A (da) Imidazodiazepinderivater
ATA296888A (de) Labyrinthanordnung
ES2024700B3 (es) 3 - ciano - 4 - fenil - pirroles
DK536788A (da) Foldeaeske
DK158489A (da) Imidazolderivater
BR6800741U (pt) Morsa independente
IT214385Z2 (it) Contenitore-espositore

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment